Genetic variation in the nucleotide excision repair pathway and bladder cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 3, 2006, Pages 536-542

  García Closas, Montserrat ^a,d   Malats, Núria ^b   Real, Francisco X ^b,c   Welch, Robert ^d   Kogevinas, Manolis ^b   Chatterjee, Nilanjan ^a   Pfeiffer, Ruth ^a   Silverman, Debra ^a   Dosemeci, Mustafa ^a   Tardón, Adonina ^e   Serra, Consol ^f   Carrato, Alfredo ^g   García Closas, Reina ^h   Castaño Vinyals, Gemma ^b   Chanock, Stephen ^a,d   Yeager, Meredith ^d   Rothman, Nathaniel ^a  

^a Division of Cancer Epidemiology and Genetics   (United States)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF OVIEDO   (Spain)

^f Department of Pediatrics   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^h Hospital Unversitario de Canarias   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 4; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 6; GENE PRODUCT; PROTEIN RAD1; PROTEIN RAD23B; TOBACCO SMOKE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ERCC1 GENE; ERCC2 GENE; ERCC4 GENE; ERCC5 GENE; ERCC6 GENE; EXCISION REPAIR; GENE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RAD23B GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPAIN; TRANSITIONAL CELL CARCINOMA; XPC GENE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NUCLEAR PROTEINS; ODDS RATIO; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SPAIN; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS; VARIATION (GENETICS);

EID: 33645520816     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0749     Document Type: Article

References (22)

1. Hoeijmakers JH. Human nucleotide excision repair syndromes: molecular clues to unexpected intricacies. Eur J Cancer 1994;30A:1912-21.
2. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001;1:22-33.
3. Neumann AS, Sturgis EM, Wei Q. Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies. Mol Carcinog 2005;42:65-92.
4. Au WW, Navasumrit P, Ruchirawat M. Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health 2004;207:301-13.
5. Vodicka P, Kumar R, Stetina R, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004;25:757-63.
6. Pavanello S, Pulliero A, Siwinska E, Mielzynska D, Clonfero E. Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers. Carcinogenesis 2005;26:169-75.
7. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1513-30.
8. Sanyal S, Festa F, Sakano S, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004;25:729-34.
9. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder. Br J Cancer 2005;92:2262-5.
10. Schabath MB, Delcloas GL, Grossman B, et al. Polymorphism in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:878-84.
11. Stern MC, Johnson LR, Bell DA, Taylor JA. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1004-11.
12. Shen M, Hung RJ, Brennan P, et al. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 2003;12:1234-40.
13. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 2001;92:562-7.
14. Garcia-Closas M, Malats N, Silverman D, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005;366:649-59.
15. Slimani N, Farran A, Torrent M. European Prospective Investigation into Cancer and Nutrition (EPIC): food composition tables-Spain. Lyon (France): International Agency for Research on Cancer (IARC); 1996.
16. Packer BR, Yeager M, Staats B, et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 2004;32:D528-32.
17. Westfall PH, Young SS. Resampling based multiple testing. New York (NY): John Wiley & Sons, Inc.; 1993.
18. Zhang H, Bonney G. Use of classification trees for association studies. Genet Epidemiol 2000;19:323-32.
19. Qiao Y, Spitz MR, Shen H, et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002;23:295-9.
20. Khan SG, Muniz-Medina V, Shahlavi T, et al. The human XPC DNA repair gene: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function. Nucleic Acids Res 2002;30:3624-31.
21. Jeon HS, Kim KM, Park SH, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003;24:1677-81.
22. Schaid DJ, McDonnell SK, Hebbring SJ, Cunningham JM, Thibodeau SN. Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet 2005;76:780-93.